Risk factors for brain metastasis in lung cancer: an umbrella review of systematic reviews and meta-analyses.
Level I
Where this comes from
- Record sourced from PubMed, PMID 39773793.
- Also identified by DOI 10.1136/bmjopen-2024-087181 and PMC identifier 11749772.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To conduct an umbrella review to extensively evaluate and summarise the evidence regarding the relationship between risk factors and the occurrence of brain metastasis in lung cancer. Umbrella review of systematic reviews and meta-analyses. Four databases (PubMed, EMBASE, Web of Science and Cochrane Library) were searched from inception to 10 November 2024. Systematic reviews and meta-analyses that assessed the relationship between risk factors and brain metastasis in lung cancer were included. Only English language studies were considered. Two authors independently extracted data and assessed the methodological quality and risk of bias of the included studies. Certainty of evidence was evaluated and summarised for each identified risk factor. Six systematic reviews/meta-analyses were included. The quality of these studies varied, with most having low or critically low methodological quality. Epidermal growth factor receptor mutations, female gender, lung adenocarcinoma and advanced tumour stage were associated with an increased risk of brain metastasis. Prophylactic cranial irradiation and older age were associated with reduced risk. This umbrella review suggests that several risk factors may be associated with brain metastasis in lung cancer, but the overall quality of evidence is low. Future studies with improved methodologies are needed to validate these findings. CRD42023484563.
Medical subject headings
- Brain Neoplasms
- Lung Neoplasms